Live from the NIH registry
Studies recruiting near Medford right now
Top 25 of 37 recruiting studies, sorted by proximity — each links to its official registry page
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
Pain
N/A
Interventional 120 participants sought
Southern Oregon Orthopedics — Medford, Oregon (1.3 mi)
· Sponsor: Synaptrix, Inc.
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Asthma
Phase 2
Interventional 50 participants sought
Enveda Investigative Site — Medford, Oregon (1.3 mi)
· Sponsor: Enveda Therapeutics
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Phase 3
Interventional 2,250 participants sought
Hematology Oncology Associates — Medford, Oregon (1.3 mi)
· Sponsor: Greenwich LifeSciences, Inc.
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi)
· Sponsor: vTv Therapeutics
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Interventional 987 participants sought
Research Site — Medford, Oregon (1.3 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Medford, Oregon (1.3 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi)
· Sponsor: Uniquity One (UNI)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Rogue Valley Medical Center — Medford, Oregon (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi)
· Sponsor: Altesa Biosciences, Inc.
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Phase 2
Interventional 402 participants sought
Copd01 50019 — Medford, Oregon (1.3 mi)
· Sponsor: UCB Biopharma SRL
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Lumbosacral Radiculopathy
Phase 3
Interventional 810 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi)
· Sponsor: Vertanical GmbH
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Breast Cancer
Phase 3
Interventional 420 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi)
· Sponsor: Hoffmann-La Roche
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Velocity Clinical Research, Grants Pass — Grants Pass, Oregon (25.3 mi)
· Sponsor: Pfizer
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Phase 3
Interventional 3,040 participants sought
Velocity Clinical Research, Medford — Medford, Oregon (1.3 mi)
· Sponsor: Bristol-Myers Squibb
Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears
Full-thickness Rotator Cuff Tear
N/A
Observational 120 participants sought
Southern Oregon Orthopedics Research Foundation — Medford, Oregon (1.3 mi)
· Sponsor: Arthrex, Inc.
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Nausea, Vomiting
Phase 2
Interventional 204 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi)
· Sponsor: Eli Lilly and Company
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Hypercholesterolemia
Phase 2
Interventional 420 participants sought
Velocity Clinical Research, Medford — Medford, Oregon (1.3 mi)
· Sponsor: Regeneron Pharmaceuticals
FiberLocker® System Augmentation of Rotator Cuff Repairs
Rotator Cuff Tear, Rotator Cuff Tears
N/A
Interventional 60 participants sought
Southern Oregon Orthopedics Research Foundation — Medford, Oregon (1.3 mi)
· Sponsor: ZuriMED Technologies Inc.
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Medford, Oregon (1.3 mi)
· Sponsor: AstraZeneca
Total Shoulder Arthroplasty Multi-Center Registry
Shoulder Arthroplasty
N/A
Observational 2,500 participants sought
Southern Oregon Orthopedics — Medford, Oregon (1.3 mi)
· Sponsor: Arthrex, Inc.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Medford, Oregon (1.3 mi)
· Sponsor: AstraZeneca
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pediatric Migraine
Phase 3
Interventional 2,100 participants sought
Velocity Clinical Research, Grants Pass — Grants Pass, Oregon (25.3 mi)
· Sponsor: Pfizer
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Pain Specialists of Southern Oregon — Medford, Oregon (1.3 mi)
· Sponsor: Boston Scientific Corporation